Akari Therapeutics, Plc
AKTX
$1.21
$0.1059.55%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -32.41% | -- | -41.83% | -90.11% | -70.98% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -69.23% | -- | 27.80% | -- | -35.70% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 32.49% | -- | -49.62% | -- | 97.00% |
| Total Current Assets | -32.00% | -- | -36.53% | -- | -68.58% |
|
|
|||||
| Total Current Assets | -32.00% | -- | -36.53% | -- | -68.58% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 279,757.14% | -- | -- | -- | -17.65% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1,061.01% | -- | -36.65% | -- | -68.52% |
|
|
|||||
| Total Accounts Payable | 642.49% | -- | 354.69% | -- | 76.45% |
| Total Accrued Expenses | 100.32% | -- | -29.85% | -- | -50.25% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -17.89% | -- | -21.73% | -- | -83.05% |
| Total Other Current Liabilities | -17.89% | -- | -21.73% | -- | -83.05% |
| Total Current Liabilities | 334.34% | -- | 67.81% | -- | -61.93% |
|
|
|||||
| Total Current Liabilities | 334.34% | -- | 67.81% | -- | -61.93% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 518.08% | -- | 67.81% | -- | -61.93% |
|
|
|||||
| Common Stock & APIC | 23.82% | -- | 7.90% | -- | 4.92% |
| Retained Earnings | -8.70% | -- | -9.13% | -- | -4.60% |
| Treasury Stock & Other | 0.59% | -- | 0.15% | -- | -0.52% |
| Total Common Equity | 9,806.99% | -- | -233.13% | -298.38% | -112.79% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 9,806.99% | -- | -233.13% | -298.38% | -112.79% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 9,806.99% | -- | -233.13% | -298.38% | -112.79% |
|
|
|||||